Cambridge Cognition

Cambridge Cognition develops CANTAB, a set of digital cognitive assessments used in clinical research and drug trials. The company describes CANTAB tests as scientifically validated, sensitive, precise and objective measures of cognitive function that are correlated to neural networks.

The tests cover four broad domains: attention and psychomotor speed, executive function, emotion and social cognition, and memory. Study teams work with the company's neuroscientists and consultants to build a battery of tasks that fits their study objectives, rather than buying one fixed test.

Cambridge Cognition lists several design choices meant to improve data quality. The tasks are language independent, which helps with consistent research across cultures. Multiple task variants let difficulty be adjusted for different ages and abilities, so results avoid floor and ceiling effects. Parallel modes and randomized stimuli reduce practice effects when people are tested more than once. Automated delivery, data capture and scoring remove variation between test administrators. The company also says the tasks are sensitive to drug and environmental effects and allow comparisons with preclinical findings.

CANTAB runs in two settings. In clinics it is delivered on iPads. For remote studies, a web based testing platform lets participants complete assessments on their own devices without supervision, with task adherence checks and on screen and voice over instructions. CANTAB Connect is the management layer that delivers touchscreen and voice assessments plus customizable electronic questionnaires and scales.

How it fits on TrueIQ: CANTAB is a professional research tool, not a consumer brain game or a quick online IQ quiz. It is sold to research sponsors and study teams, so there is no public price list. If you are comparing it with consumer apps such as Lumosity or BrainHQ in this category, the key difference is purpose: CANTAB measures cognition for studies, while those apps aim to train it.